To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Salaries and Expenses for fiscal year 2024.

HR 2071 limits funding for the Office of National Drug Control Policy (ONDCP) within the Executive Office of the President to $18.4 million for fiscal year 2024. This bill directly affects the ONDCP's budget for salaries and operations, capping its available funds at the specified amount. It does not alter drug policy or create new programs, but instead enforces a strict spending restriction on the office's existing budget authority. The provision applies to all funds authorized for the ONDCP's Salaries and Expenses account during FY2024.